American Century Companies’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
Other funds holding KURA
SCM
BI
AC
ACM
American Century Companies's KURA Position: Q2 2026 in Review
American Century Companies reduced its Kura Oncology (KURA) stake by 81% in Q2 2026, selling an estimated $3.7M and leaving 94,198 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #2393.
American Century Companies first reported a position in KURA in Q3 2022 and has held it in 16 quarters since. The position peaked at $11.6M in Q4 2025. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.
- American Century Companies held 94,198 shares of Kura Oncology worth $1.03M as of Q2 2026.
- American Century Companies sold 392,372 Kura Oncology shares in Q2 2026, an estimated $3.7M.
- Kura Oncology made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2393 holding.
- American Century Companies first reported a position in Kura Oncology in Q3 2022 and has held it in 16 quarters since.
- American Century Companies's Kura Oncology position peaked at $11.6M in Q4 2025.
- 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.